Moreover, our results showed that the mRNA and protein expression levels of MMP2 and MMP9 were significantly increased in SPM, WPM or PAH-treated VSMCs, which is consistent with previous reports that ROS can directly or indirectly activate MMP2 and MMP9 in VSMCs [41, 44]. The gene discussed is MMP9; the disease is pulmonary arterial hypertension.